Molluscum Contagiosum: Meaning, Causes, Symptoms and Treatment: By Shimona Patel Molluscum contagiosum is a frequently encountered viral skin infection, caused by the molluscum contagiosum virus (MCV) ...
Molluscum contagiosum (MC), a viral skin infection caused by the poxvirus, often presents challenges in treatment due to limited therapeutic options. However, a potential breakthrough has emerged with ...
Please provide your email address to receive an email when new articles are posted on . The approval was based on results from two phase 3 randomized, double-blind, multicenter trials, CAMP-1 and CAMP ...
Credit: Pelthos Therapeutics. Equal amounts of gel from Tube A and Tube B should be dispensed and mixed on the dosing guide. The treatment can be applied at home by the patient or caregiver. Zelsuvmi ...
Please provide your email address to receive an email when new articles are posted on . MIAMI BEACH, Fla. — Two new treatment options for molluscum contagiosum could be available in the near future as ...
The U.S. Food and Drug Administration has approved the topical solution Ycanth (cantharidin) for the treatment of molluscum contagiosum (molluscum) in adult and pediatric patients (aged 2 years and ...
Topical cantharidin (Ycanth) was approved as the first treatment specifically for molluscum contagiosum, the FDA announced. Molluscum contagiosum is a viral skin infection that affects as many as 6 ...
Analysis shows YCANTH achieved complete clearance of molluscum contagiosum approximately 4 times faster than vehicle, regardless of disease duration – WEST CHESTER, Pa., Sept. 30, 2026 (GLOBE NEWSWIRE ...
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S. Food and Drug Administration (FDA) has approved ZELSUVMI™ (berdazimer topical gel, 10.3%) ...
"It's 3 a.m. and I'm in the hospital because I bought a wig off of Amazon," writer Kayla Knight says in a video posted to her TikTok account. In it, Knight is seen in a hospital gown and bonnet with ...
DURHAM, N.C., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), announced today that the Company has submitted a New Drug Application (NDA) to the U.S. Food and ...
Zelsuvmi is expected to be available in the second half of 2024. The Food and Drug Administration (FDA) has approved Zelsuvmi ™ (berdazimer topical gel) for the treatment of molluscum contagiosum in ...